Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:approvedBy |
gptkb:FDA
leukemia multiple myeloma |
| gptkbp:ATCCode |
L03AX16
|
| gptkbp:brand |
Mozobil
|
| gptkbp:CASNumber |
110078-46-1
|
| gptkbp:contraindication |
pregnancy
|
| gptkbp:discoveredBy |
AnorMED
|
| gptkbp:hasMolecularFormula |
C28H54N8
|
| https://www.w3.org/2000/01/rdf-schema#label |
plerixafor
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
CXCR4 antagonist
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
nausea
diarrhea headache injection site reactions |
| gptkbp:synonym |
gptkb:AMD3100
|
| gptkbp:usedFor |
gptkb:granulocyte_colony-stimulating_factor
hematopoietic stem cell mobilization |
| gptkbp:bfsParent |
gptkb:MGTA-145
gptkb:CXCR4_co-receptor gptkb:CXCR4 |
| gptkbp:bfsLayer |
7
|